4//SEC Filing
Lagan Seamus 4
Accession 0001493152-18-010468
CIK 0000931059other
Filed
Jul 24, 8:00 PM ET
Accepted
Jul 25, 4:28 PM ET
Size
21.0 KB
Accession
0001493152-18-010468
Insider Transaction Report
Form 4
Lagan Seamus
DirectorCEO and President
Transactions
- Award
Series J Convertible Preferred Stock
2018-07-23$1.00/sh+250,000$250,000→ 250,000 total(indirect: By LLC)Exercise: $0.00From: 2018-07-23→ Common Stock (147,058,824 underlying)
Alcimede LLC
Other
Transactions
- Award
Series J Convertible Preferred Stock
2018-07-23$1.00/sh+250,000$250,000→ 250,000 total(indirect: By LLC)Exercise: $0.00From: 2018-07-23→ Common Stock (147,058,824 underlying)
Footnotes (5)
- [F1]As of July 23, 2018. The conversion price equals the average closing price of the common stock for the 10 trading days prior to the conversion date.
- [F2]Based on the conversion price as of July 23, 2018.
- [F3]Each share of the Series J Convertible Preferred Stock has the number of votes equal to the number of shares of common stock into which it is convertible, except that, for certain specified matters, through September 30, 2018 only each share has 12,000 votes.
- [F4]Alcimede LLC received the shares in exchange for the cancellation of outstanding debt.
- [F5]The Series J Preferred Stock will remain outstanding until either converted or redeemed by the Company.
Documents
Issuer
Rennova Health, Inc.
CIK 0000931059
Entity typeother
Related Parties
1- filerCIK 0001588135
Filing Metadata
- Form type
- 4
- Filed
- Jul 24, 8:00 PM ET
- Accepted
- Jul 25, 4:28 PM ET
- Size
- 21.0 KB